We are live on
!
Find out more
HCM
Hall Capital Management Portfolio holdings
AUM
$280M
1-Year Est. Return
14.82%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+14.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
+$16.9M
(+7.1%)
Cap. Flow
+$3.39M
Cap. Flow
% of AUM
1.33%
Top 10 Holdings %
Top 10 Hldgs %
45.3%
Holding
98
New
4
Increased
29
Reduced
43
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$1.6M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.59M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.09M |
| 4 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$773K |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$207K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.53M |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$321K |
| 3 |
Oracle
ORCL
|
+$146K |
| 4 |
Merck
MRK
|
+$119K |
| 5 |
Microsoft
MSFT
|
+$117K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Financials | 9.25% |
| 3 | Consumer Staples | 9.09% |
| 4 | Healthcare | 7.54% |
| 5 | Industrials | 6.69% |
Similar funds
PBPIA
JPLA
ACC
BWG
KF
OFCM
NCM
PHC
Hall Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Hall Capital Management held 98 positions worth $254M, up 7.1% from $237M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.1%. Hall Capital Management opened 4 new positions and made no exits, leaving the 98-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Staples.
- Hall Capital Management's largest Q3 2025 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 1,806 shares worth $216K.
- Hall Capital Management added most to Boston Scientific in Q3 2025, an estimated $1.6M increase.
- Hall Capital Management's biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.53M.
- Hall Capital Management's ten largest holdings make up 45% of its $254M portfolio in Q3 2025.
- Hall Capital Management opened 4 new positions and closed 0 in Q3 2025.
- Hall Capital Management's portfolio value rose 7.1% quarter-over-quarter to $254M.
Based on Hall Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.